Join our dedicated team

Specialized team of scientists

BSL 2 & BSL 3 Facilities

Large Scale Diagnostic Services

Specialized Consultancy Services

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.

Virology Contract Research Laboratory

Specialized team of scientists

BSL 2 & BSL 3 Facilities

Large Scale Diagnostic Services

Specialized Consultancy Services

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.

Vacancy

Are you looking for a role that will expand your career in preclinical services? Do you want to work for a company that is a world leader in preclinical development? Then we might have a vacancy for you!

Study Director (Fulltime)

 

Task

In this position you will be working in the business unit of Viroclinics Xplore which covers early-stage research and preclinical services. Viroclinics Xplore is responsible for the preclinical testing of vaccines and antiviral drugs against virus diseases. You will be managing assigned preclinical studies acting as a Study Director and report directly to the general manager. In this function you will be concerned with the design and planning of experiments, obtaining ethics approval (on project proposals and working protocols), undertaking experiments, preparing and getting approval for all documents related to preclinical experiments (such as protocols and reports). You will be working at the Nistelrooise Baan in Schaijk, where our unit is based.

The following tasks will be a part of your responsibilities:

  • You inform the operations manager about all the resources you need for the proper conduct of the assigned projects on a daily basis. while being in the lab and animal room at critical moments yourself to be fully in control;
  • You performed lab techniques like PCR, virus titrations; antibody detection assays, like ELISA, hemagglutination inhibition and virus neutralization according to (ISO15189/GLP) quality standards by using standards operating procedures (SOPs) and forms in the lab;
  • You will maintain adequate communication with colleagues and third parties to ensure swift project progress and delivery of milestones;
  • You work safely with pathogenic viruses (BSL-2, BSL-3);
  • You will work closely together with your peers, a team of three other Study Directors;
  • You will be involved in project acquisition and business development activities.

Personal competences

We are looking for a person with attention to detail and focus on quality. It is important that you are flexible and possess excellent communication skills. You are loyal, reliable and responsible. You are able and willing to work outside normal business hours and at different locations. Furthermore, it is important that you know how to manage people that are concerned with the study that you are directing.

Education and experience

  • PhD in Microbiology, virology and/or immunology is a must;
  • Working experience in a BSL-2/3 laboratory or willing to follow the required training;
  • We would appreciate your documented experience to work in a BSL-2/3 laboratory or otherwise;
  • Laboratory animal science article 9 certification is a must.

Terms of employment

Study Director is a fulltime position, for 40 hours a week. We offer you a salary that corresponds with your education, experience and our company policy. We offer you a one-year contract with the possibility of extension and a permanent contract upon good performance. Furthermore, you will receive 8% holiday allowance and travel allowance.

Company profile

Viroclinics Biosciences is a leader in the strongly growing and very dynamic market of diagnostic services companies. As a service organization we offer serological, virus-based and molecular analyses of any type of sample and combine this with a global logistics service network. We have customers from all over the world and our analyses encompass many types of viruses.

Professionalism and high quality standards are hallmarks of our organization. Our company is steadily growing and in recent months we obtained several new requests to participate in global phase-2 and phase-3 drug development programs. The 160 employees of Viroclinics are diverse and motivated. Viroclinics is a Dutch company and the majority of your future colleagues is also Dutch.

To apply for this position

Would you like to be a part of our Xplore team as Study Director? Please send your CV and motivation letter to Madri Singh, HR Officer, via recruitment@viroclinics.com. For further information about the vacancy, please contact us at ++316 57389380

OUR LATEST NEWS

International partnership progresses UQ COVID-19 vaccine project

9 April 2020 The University of Queensland’s potential COVID-19 vaccine is entering an important new phase of testing with the live coronavirus to determine how effectively it induces protection against coronavirus infection. The UQ team will partner with the Dutch...

Viroclinics-DDL Team to Support COVID-19 New Drug Investigations

Preceding weeks have made clear that COVID-19 continues to spread and is paralyzing the world. Times are unprecedented and show us how vulnerable we are and how we depend on each other. As a service organization – highly specialized in virology – we will commit ourselves to realign our resources, equipment and materials to new initiatives to test anti-virals, immune modulators and vaccines in the battle against COVID-19.

Summit Partners Announces Growth Equity Investment in Viroclinics Biosciences

Global growth equity investor Summit Partners today announced a majority investment in Viroclinics Biosciences B.V., a leading specialized contract research organization (CRO) serving the global biopharmaceutical industry. The funding will be used to fuel continued expansion of Viroclinics’ services, capacity and international presence.

↓